PsychoGenics Inc. and its discovery arm, PGI Drug Discovery LLC (collectively known as PsychoGenics), have pioneered the translation of rodent beha vioral and physiological responses into robust, high-throughput and high-content phenotyping. PsychoGenics' drug discovery platforms, SmartCube®, NeuroCube®, PhenoCube®, and eCube have been used in shared-risk partnerships with major pharma companies including Sunovion, Roche, and Karuna, resulting in the discovery of several novel compounds now in clinical trials or advanced preclinical development. PsychoGenics' capabilities also include standard behavioral testing, electrophysiology, translational EEG, molecular biology, microdialysis, and quantitative immunohistochemistry. In addition, the company offers a variety of in-licensed transgenic mouse models that support research in areas such as Huntington's disease, autism spectrum disorders, psychosis/schizophrenia, depression, PTSD, Alzheimer's disease, Parkinson's disease, muscular dystrophy, ALS, and seizure disorders.Read more
PsychoGenics's Social Media
Popular SearchesPsychogenics IncPsychogenicsPsychogenics AsLundbeck Research USALundbeck Research Usa IncSIC Code 87,873NAICS Code 54,541Show more
